| Meet the ANRF THE FOUNDATION The Arthritis National Research Foundation provides funding for highly qualified researchers associated with major research institutes, universities and hospitals throughout the country seeking to discover new knowledge for the prevention, treatment and cure of arthritis and related rheumatic diseases. The foundation receives no government funding; it operates solely through the generosity of individual contributions. THE ROAD TO A CURE Since 1952, the Arthritis National Research Foundation (ANRF) has funded the work of leading researchers seeking improved treatment and the ultimate cure of arthritis. Research breakthroughs resulting from ANRF grants include:
The more we learn about the causes of arthritis, the closer we get to a cure. The discoveries made by todays researchers pave the way for new treatments tomorrow. Arthritis is progressive and erodes the physical endurance and pain tolerance of its sufferers. It claims a new victim every 33 seconds. The search for a cure must continue. |
ANRF SCIENTIFIC ADVISORY BOARD The Arthritis National Research Foundations mission is to provide grant funds to young investigators studying the causes of and new treatments for arthritis. ANRF has called upon top researchers and scientists to become members of a newly formed Scientific Advisory Board. The doctors of the Scientific Advisory Board are respected nationwide for their individual expertise in the field of arthritis and immunological research.
The individual members of ANRFs Scientific Advisory Board have committed their expertise to furthering the principles and goals of our organization on a regular basis. These scientists believe that ANRF plays a critical role in the field of rheumatic disease research: the Foundation funds young investigators, often giving them a "jump start" on their research careers. The Advisory Board members will be reviewing the grant proposals received by ANRF each year and recommend grant recipients, as well as providing advice to the Board of Directors on the trends in research and clinical treatments.
The Scientific Advisory Board will be instrumental in implementing the organizations goal of funding more research projects each year.
MEET THE SCIENTIFIC ADVISORY BOARD
John H. Vaughan, M.D., University of California, San Diego Dr. Vaughan is a past president of the American College of Rheumatology and has been studying the pathogenesis of rheumatoid arthritis throughout his career. A graduate of Harvard Medical School, Dr. Vaughan has directed the Immunology and Infectious Diseases Unit of the University of Rochester Medical School (1963-70), chaired the Clinical Research Department and the Clinical Immunology Department at Scripps Research Institute (1970-1989), and has been a Professor of Medicine at the University of California, San Diego since 1990.
Dr. Vaughans career has been in teaching and research in the areas of allergy and the autoimmune diseases, such as rheumatoid arthritis. His major research contributions have been in elucidating the nature and significance of autoantibodies, early studies on the nature of cellular immunity, and more recent explorations of the probable contribution of virus infection in the autoimmune diseases. Dr. Vaughan is a former grant recipient of ANRF.
James Klinenberg, M.D., Cedars-Sinai Medical Center, Los Angeles Dr. Klinenberg has served as president of the American College of Rheumatology and is currently Professor of Medicine and Assistant Dean of the UCLA School of Medicine. He earned his M.D. from the George Washington School of Medicine in 1959; his undergraduate and M.A. work was completed at Johns Hopkins University.
In addition to the American College of Rheumatology presidency, Dr. Klinenberg has held numerous positions of leadership in education, research and professional organizations, including the Association of American Medical Colleges, American College of Physicians, California Biomedical Research Association, local and national Arthritis Foundation, and Cedars-Sinai Medical Center. His research throughout most of his career has focused on the causes and mechanisms of rheumatic diseases, with an emphasis on the autoimmune diseases of lupus and rheumatoid arthritis.
Hugh McDevitt, M.D., Stanford University Medical Center Dr. McDevitt is known world-wide for his contributions to the field of arthritis research. He is currently a professor of Medicine, and Microbiology & Immunology at the Stanford University School of Medicine. A 1955 graduate of Harvard University Medical School, Dr. McDevitt has received honors and awards for his research-related work from academic and professional organizations ranging from the National Institutes of Health to the National Cancer Institute to the American College of Rheumatology, and more.
He currently serves on the Advisory Committee to the Director of the National Institutes of Health, as well as on the editorial boards of the publications, Molecular Medicine and The Journal of Clinical Immunology, Immunopathology, Immunogenetics. At Stanford University, Dr. McDevitt has been the head of the Immunology Department, the director of the Clinical Immunology Lab, and Chairman of the Department of Microbiology and Immunology.
Grete Sonderstrup, M.D., Stanford University Medical Center Dr. Sonderstrup is an Assistant Professor of Medicine in the Division of Immunology and Rheumatology at Stanford University Medical Center. She earned her M.D. from the University of Copenhagen in 1974, coming to the U.S. in 1986 to continue her research in immunology. Dr. Sonderstrup is a speaker in high demand, having been invited to universities and conferences all over the world to discuss her research work in rheumatoid arthritis. ANRF provided funding for Dr. Sonderstrups work in 1993.
Eng M. Tan, M.D., Scripps Research Institute Dr. Tan is Professor and Head of the Autoimmune Disease Center at the Scripps Research Institute in La Jolla, CA. He earned his M.D. degree from Johns Hopkins University in 1956. After his medical internship and residency, Dr. Tan began his post-doctoral research at Case Western Reserve University in Cleveland, then Rockefeller University in New York. He joined the Scripps Clinic and Research Foundation in 1967, and was head of the Department of Allergy & Immunology from 1970 to 1977. Since 1982, Dr. Tan has been head of the W.M. Keck Autoimmune Disease Center, where his work has centered on studies of autoantigens and autoantibodies in systemic rheumatic diseases and cancer.
Dr. Tan is a past president of the American Rheumatism Association, and has served on numerous advisory boards and research committees for the National Institutes of Health and various national scientific and medical organizations. In recognition of his achievement in this research field, Dr. Tan has received awards from organizations worldwide.
Carl F. Ware, Ph.D., La Jolla Institute for Allergy and Immunology Dr. Ware received his Ph.D. from the University of California, Irvine in Molecular Biology and Biochemistry in 1979. He did his postdoctoral research at the University of Texas, Health Science Center, San Antonio, the Dana-Farber Cancer Institute in Boston, and the Department of Microbiology and Molecular Genetics at Harvard Medical School. Dr. Ware joined the La Jolla Institute for Allergy and Immunology (LIAI) in 1996 as Head and Member of the Division of Molecular Immunology and is also currently Adjunct Professor of Biology at the University of California, San Diego.
A major goal of LIAIs projects in Molecular Immunology is to understand how lymphotoxins and TNF, and newly discovered proteins induce cell death and growth, and to research the underlying factors that regulate the human immune system. Dr. Ware is considered an expert in the field of molecular immunology.
ARTHRITIS NATIONAL
RESEARCH FOUNDATION
1998-99 BOARD OF DIRECTORS
| Officers
|
|
| Helen
Z. Hansen, Education President |
Education Consultant |
| James
Rose, Pharm.D. President/Elect |
CareMore Medical Group |
| Mark
Schulten Secretary-Treasurer |
Salomon Smith Barney, Inc. |
|
|
|
| Jay Beeler | Beeler & Associates |
| Kevin Donohue | Morgan Stanley Dean Witter |
| Kathryn Ferris | Morgan Stanley Dean Witter |
| Gale A. Granger, Ph.D. | University of California, Irvine |
| Travis A. Montgomery | The Queen Mary |
| Lynn E. Moyer, Esq. | Hill, Betts & Nash, LLP |
| James D. Wallace, M.D. | Long Beach Memorial Medical Center |
| Robert A. Wiswell, Ph.D. | University of Southern California |
Helene Belisle Executive Director |
Arthritis National Research Foundation |
Scientific Advisory Board |
|
| John H. Vaughan, M.D. | University of California, San Diego |
| James R. Klinenberg, M.D. | Cedars-Sinai Medical Center |
| Hugh McDevitt, M.D. | Stanford University School of Medicine |
| Grete Sonderstrup-McDevitt, M.D. | Stanford University School of Medicine |
| Eng M. Tan, M.D. | Scripps Research Institute |
| Carl F. Ware, Ph.D. | La Jolla Institute for Allergy & Immunology |
[Meet the ANRF] [Latest
Research] [Support the Research] [Our
Sponsors] [Awards]
[Grant Application Guidelines [CureArthritis
Newsletter] [Arthritis Info & Links] [Contact Us]
This page, and all the contents of this Web
site,
are Copyright © 1999 by TouchVision,
Seal Beach, California. All rights reserved.
Best experienced with